Indication
Obesity due to proprotein convertase subtilisin/kexin type 1 (PCSK1) deficiency
Obesity due to proprotein convertase subtilisin/kexin type 1 (PCSK1) deficiency is an ultra-rare, autosomal recessive neuroendocrine disorder caused by biallelic loss-of-function variants in the *PCSK1* gene. Read more about Obesity due to proprotein convertase subtilisin/kexin type 1 (PCSK1) deficiency
1 drugs 1 manufacturers
Drugs that treat it
Common Obesity due to proprotein convertase subtilisin/kexin type 1 (PCSK1) deficiency therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonObesity due to proprotein convertase subtilisin/kexin type 1 (PCSK1) deficiency is an ultra-rare, autosomal recessive neuroendocrine disorder caused by biallelic loss-of-function variants in the *PCSK1* gene.
The gene encodes prohormone convertase 1/3 (PC1/3), an endoprotease crucial for processing peptide hormone and neuropeptide precursors within the neuroendocrine system and central appetite-regulating pathways, including proopiomelanocortin (POMC) and proinsulin.
Impaired maturation of these regulatory peptides disrupts central satiety signaling within the hypothalamic melanocortin pathway, resulting in severe early-onset hyperphagia and rapid, progressive obesity that typically manifests in early childhood following neonatal generalized enteropathy and failure to thrive.
Affected pediatric and adult patients frequently present with a complex systemic endocrinopathy, characterized by marked hyperproinsulinemia, central hypoadrenalism, hypogonadotropic hypogonadism, central hypothyroidism, and diabetes insipidus.
- differentobesity.com
Obesity due to proprotein convertase subtilisin/kexin type 1 (PCSK1) deficiency is an ultra-rare, autosomal recessive neuroendocrine disorder caused by biallelic loss-of-function variants in the *PCSK1* gene Impaired maturation of these regulatory peptides disrupts central satiety signaling within the hypothalamic melanocortin pathway, resulting in severe early-onset hyperphagia and rapid, progressive obesity that typically manifests in early childhood following neonatal generalized enteropathy ...
- rarediseases.org
Obesity due to proprotein convertase subtilisin/kexin type 1 (PCSK1) deficiency is an ultra-rare, autosomal recessive neuroendocrine disorder caused by biallelic loss-of-function variants in the *PCSK1* gene Impaired maturation of these regulatory peptides disrupts central satiety signaling within the hypothalamic melanocortin pathway, resulting in severe early-onset hyperphagia and rapid, progressive obesity that typically manifests in early childhood following neonatal generalized enteropathy ...
- orpha.net
Obesity due to proprotein convertase subtilisin/kexin type 1 (PCSK1) deficiency is an ultra-rare, autosomal recessive neuroendocrine disorder caused by biallelic loss-of-function variants in the *PCSK1* gene Affected pediatric and adult patients frequently present with a complex systemic endocrinopathy, characterized by marked hyperproinsulinemia, central hypoadrenalism, hypogonadotropic hypogonadism, central hypothyroidism, and diabetes insipidus
- nih.gov
Obesity due to proprotein convertase subtilisin/kexin type 1 (PCSK1) deficiency is an ultra-rare, autosomal recessive neuroendocrine disorder caused by biallelic loss-of-function variants in the *PCSK1* gene The gene encodes prohormone convertase 1/3 (PC1/3), an endoprotease crucial for processing peptide hormone and neuropeptide precursors within the neuroendocrine system and central appetite-regulating pathways, including proopiomelanocortin (POMC) and proinsulin
- nih.gov
The gene encodes prohormone convertase 1/3 (PC1/3), an endoprotease crucial for processing peptide hormone and neuropeptide precursors within the neuroendocrine system and central appetite-regulating pathways, including proopiomelanocortin (POMC) and proinsulin
- cam.ac.uk
The gene encodes prohormone convertase 1/3 (PC1/3), an endoprotease crucial for processing peptide hormone and neuropeptide precursors within the neuroendocrine system and central appetite-regulating pathways, including proopiomelanocortin (POMC) and proinsulin Affected pediatric and adult patients frequently present with a complex systemic endocrinopathy, characterized by marked hyperproinsulinemia, central hypoadrenalism, hypogonadotropic hypogonadism, central hypothyroidism, and diabetes insi...
- oup.com
Impaired maturation of these regulatory peptides disrupts central satiety signaling within the hypothalamic melanocortin pathway, resulting in severe early-onset hyperphagia and rapid, progressive obesity that typically manifests in early childhood following neonatal generalized enteropathy and failure to thrive
- incitefulmed.com
Impaired maturation of these regulatory peptides disrupts central satiety signaling within the hypothalamic melanocortin pathway, resulting in severe early-onset hyperphagia and rapid, progressive obesity that typically manifests in early childhood following neonatal generalized enteropathy and failure to thrive
- atlasgeneticsoncology.org
Affected pediatric and adult patients frequently present with a complex systemic endocrinopathy, characterized by marked hyperproinsulinemia, central hypoadrenalism, hypogonadotropic hypogonadism, central hypothyroidism, and diabetes insipidus
Personalize your experience
Follow Obesity due to proprotein convertase subtilisin/kexin type 1 (PCSK1) deficiency and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.